Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) EBITDA: 2020

Historic EBITDA for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to -$3.9 million.

  • Design Therapeutics' EBITDA was N/A to -$3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$8.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Design Therapeutics reported EBITDA of -$3.9 million as of Q4 2020, which was down 62.02% from -$2.4 million recorded in Q3 2020.
  • Over the past 5 years, Design Therapeutics' EBITDA peaked at -$623,000 during Q1 2020, and registered a low of -$3.9 million during Q4 2020.
  • For the 1-year period, Design Therapeutics' EBITDA averaged around -$2.1 million, with its median value being -$1.9 million (2020).